Ibrutinib (I) plus bendamustine and rituximab (BR) in previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): a 2-year follow-up of the HELIOS study Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Cramer, P
  • Fraser, Graeme
  • Chanan-Khan, A
  • Demirkan, F
  • Silva, Santucci R
  • Pylypenko, H
  • Grosicki, S
  • Janssens, A
  • Pristupa, A
  • Mayer, J
  • Dilhuydy, M-S
  • Loscertales, J
  • Goy, A
  • Avigdor, A
  • Rule, S
  • Phelps, C
  • Mahler, M
  • Salman, M
  • Howes, A
  • Balasubramanian, S
  • Hallek, M

publication date

  • October 1, 2016